InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by Hunt Anthony, Chairman & CEO. Director active across 2 companies, notably Repligen CORP. Cumulatively, 11 disclosures have been recorded. Total volume traded: €169k. The latest transaction was filed on 1 March 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€1m7,292 shares@ €173.02190.022% mcap43.7% of flow
Common Stock
SEC:0000899243-22-009046:0·
€484,0742,754 shares@ €175.77110.0083% mcap16.8% of flow
Common Stock
SEC:0000899243-22-008750:0·
015,855 shares0
Common Stock
SEC:0000899243-22-008191:0·
€286,18910,000 shares@ €28.61890.0031% mcap29.5% of flow
Common Stock
SEC:0000899243-21-045407·
€286,18910,000 shares@ €28.61890.0049% mcap9.9% of flow
Common Stock
SEC:0000899243-21-045407:0·
€684,93625,000 shares@ €27.39740.0074% mcap70.5% of flow
Common Stock
SEC:0000899243-21-035722·
€684,93625,000 shares@ €27.39740.012% mcap23.7% of flow
Common Stock
SEC:0000899243-21-035722:0·
01,000 shares0
Common Stock
SEC:0000899243-21-033450·
01,000 shares0
Common Stock
SEC:0000899243-21-033450:0·
€84,609612 shares@ €138.2502100.0% of flow
Common Stock
SEC:0000899243-21-020294·
€84,609612 shares@ €138.25020.0015% mcap2.9% of flow
Common Stock
SEC:0000899243-21-020294:0·
11 of 11 declarations
About Hunt Anthony
Anthony Hunt is the Chief Executive Officer of Repligen Corp. He leads the company in its efforts to develop innovative solutions in the biotechnology field, focusing on improving drug manufacturing and purification processes.
